Atrial Fibrillation Ablation Study
Part of Heart & circulation clinical trials.
This study is for people with atrial fibrillation who are planning to have a catheter ablation procedure. It will look at how well the heart works after the procedure and how to prevent future events.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have atrial fibrillation and plan to have a catheter ablation procedure
- You have not had a blood clot in your left atrium, a new stroke, or heart attack in the last 6 months
- You do not have certain heart conditions like congenital heart disease, valve disease, or a pacemaker
- You have not had a catheter ablation before
- You can have a clear 3D ultrasound image of your heart (transesophageal echo)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether catheter ablation (a procedure to correct irregular heartbeats) helps people with atrial fibrillation who have already had a successful MitraClip repair for a leaky mitral valve. It aims to see if the ablation improves heart rhythm and quality of life.
This study tests whether a catheter ablation procedure (a way to fix abnormal heart rhythms) can help people who have both constant atrial fibrillation and severe mitral regurgitation (a leaky heart valve). It is for people whose heart valve leak is caused by the rhythm problem, not by valve damage.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
This study tests a new combination of treatments for people who have had atrial fibrillation (a type of irregular heartbeat) continuously for 1 to 3 years. The goal is to find a better way to restore normal heart rhythm and improve symptoms.
This study looks at how often silent brain lesions happen after a new type of heart procedure for atrial fibrillation (an irregular heartbeat). The procedure uses a device called the Varipulse catheter to help fix the heart's rhythm.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.